Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study

Gelijkaardige items

• The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer
  door: Nerina C. van der Merwe, et al.
  Gepubliceerd in: (2020-05-01)
• The contribution of large genomic rearrangements in BRCA1 and BRCA2 to South African familial breast cancer
  door: van der Merwe, Nerina C., et al.
  Gepubliceerd in: (2020)
• Clinical Overestimation of HER2 Positivity in Early Estrogen and Progesterone Receptor–Positive Breast Cancer and the Value of Molecular Subtyping Using BluePrint
  door: Ettienne J. Myburgh, et al.
  Gepubliceerd in: (2017-08-01)
• Clinical Overestimation of HER2 Positivity in Early Estrogen and Progesterone Receptor–Positive Breast Cancer and the Value of Molecular Subtyping Using BluePrint
  door: Myburgh, Ettienne J., et al.
  Gepubliceerd in: (2016)
• Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing
  door: Rispah Torrorey-Sawe, et al.
  Gepubliceerd in: (2020-03-01)